|
Members of the Executive Committee - EC The role of the EC is to stimulate collaboration, set priorities, and help investigators and the senior management team with design, implementation, and operations of their projects.
| Professor Z Mike Chirenje, MD FRCOG, (University of Zimbabwe) Executive Director and EC Chairman Biosketch: Mike Chirenje, MD FRCOG, is a Gynecological Oncologist & Associate Professor in the Department of Obstetrics and Gynecology College of Health Science, University of Zimbabwe, Harare. His main research interest is cervical cancer screening and treatment of pre-cancer lesions in low resource settings. He is a member of WHO HPV Vaccine Expert Advisory Committee, and board member of African Organisation on Research and Training in Cancer. He is a founding member and Executive Director of a large Harare based collaborative Research Programme University of Zimbabwe – University of California San Francisco (UZ-UCSF). Dr Chirenje was Principal Investigator for a large protocol that screened 11 000 women in Harare which became internationally a milestone study to demonstrate effectiveness of VIA in screening cervical cancer in low resource countries. Dr. Chirenje is currently Principle Investigator for a WHO operative research protocol assessing implementation of Cervical Cancer Screening by visual inspection with acetic acid and cyrotheray treatment in six African countries (Nigeria, Malawi, Zambia, Madagascar, Tanzania and Uganda) Dr. Chirenje has also evaluated HPV screening and he is currently following a cohort to establish HPV types among Zimbabwean women with invasive cervical cancer. He is also Principal Investigator for a large NIH funded HIV Clinical Trials Unit (UZ-UCSF) that is evaluating several HIV prevention methods including vaginal microbicides in HIV uninfected women as well oral pre-exposure prophylaxis (Pr-EP) of anti-retroviral drugs | | | | | | | | Dr. Tsungai Chipato (University of Zimbabwe) | Dr. Tsungai Chipato Biosketch Dr. Chipato is an Obstetrician and Gynecologist by training and is Associate Professor and Consultant Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology in the University of Zimbabwe College of Health Sciences. He studied Medicine at the University of Bristol, UK, and undertook postgraduate studies at Bristol Maternity Hospital, St Mary’s Hospital School of Medicine, London and Harare Central Hospital in Zimbabwe. He did subspecialty training in Gynecologic endocrinology at St Mary’s Hospital and at the Monash Medical Center, Melbourne, Australia. He trained in Clinical Epidemiology at the University of Pennsylvania, Philadelphia, USA. He is a founder member of the UZ-UCSF Collaborative Research Program in Women’s Reproductive Health, serving as the inaugural Principal Investigator of the UZ-UCSF HIV Prevention Trials Unit affiliated with the NIH-funded HIV Prevention Trials Network (HPTN), the precursor to the UZ-UCSF HIV Clinical Trials Unit. Dr Chipato’s research has encompassed the fields of contraception particularly contraceptive implants which he helped to introduce into Zimbabwe, Barrier Methods of HIV Prevention, prevention of cervical cancer and screening for cervical pre-cancer using visual inspection, post abortion care and prevention of HIV vertical transmission. Along with Dr Chirenje, he was Principal Investigator of a large clinical trial to evaluate the utility of Visual Inspection of the cervix as a screening test for cervical premalignant lesions. He has worked and collaborated with international health organizations including the WHO, Commonwealth Regional Health Secretariat for East Central Africa and IPAS. In Zimbabwe he is a long time member of the Board of the Zimbabwe National Family Planning Council, The Medical Research Council of Zimbabwe and the National Reproductive Health Committee. In the past he served as a member of the WHO Taskforce on Infertility , WHO Research and Evaluation Committee and the DAIDS Africa HIV Clinical Trials DSMB. He is a current member of the WHO Contraception Medical Eligibility Recommendations Committee. RESEARCH INTERESTS 1) Contraception and Barrier methods of HIV prevention 2) Prevention of Mother To Child HIV–PMTCT 3) STI and Cervical Cancer screening and prevention 4) Post-abortion and Abortion Care 5) HIV prevention |
| | | | | Professor James Hakim, FRCP (University of Zimbabwe) Dr. James Hakim, FRCP is Chairman of the Department Medicine at the University of Zimbabwe College of Health Sciences in Harare. He is an internal medicine specialist and a clinical epidemiologist at the University. He has worked collaboratively with colleagues at the University of Colorado Health Sciences Centre and University of California, San Francisco to establish an AIDS research and care program in Zimbabwe over the past 6 years. Dr Hakim has been on the faculty of the University of Zimbabwe since 1992. Following graduation from Makerere University Medical School in Uganda he undertook specialization in internal medicine at the University of Nairobi, Kenya and the Royal Colleges of Physicians in the United Kingdom. He later received training as a clinical epidemiologist with the University of Newcastle, Australia. | | | | | Dr. Suellen Miller, PhD, RN, CNM, MHA (University of California in San Francisco)
Associate Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF
Director, Safe Motherhood Programs, Bixby Center for Global Reproductive Health, UCSF Associate Professor, Maternal Child Health Program, School of Public Health, University of California, Berkeley, and Adjunct Faculty, Joint Medical Program, SPH, UCB and Medical School, UCSF Email:
This email address is being protected from spam bots, you need Javascript enabled to view it
Biosketch: Dr. Miller is the Director of Safe Motherhood Programs at the Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, and on the faculty of the Maternal and Child Health Program at UC Berkeley’s School of Public Health and the faculty of the Joint Medical Program, UCB/UCSF. The Safe Motherhood Program comprises intervention projects and research on critical maternal health issues. Dr. Miller is the principal investigator on multiple studies of the Non-pneumatic Anti-Shock Garment (NASG) for the management of obstetric hemorrhage, in Nigeria, India, Egypt, Zimbabwe, and Zambia. This study includes comparative projects in hospitals in Egypt and Northern and Southern Nigeria, and randomized cluster trails at midwife-staffed primary health care centers in Zimbabwe and Zambia. She is also working on Continuum of Care for Post Partum Hemorrhage Projects, a multi-phase community to facility maternal health project in Nigeria and India,. She is a consultant on maternal health to the Millennium Development Villages in Ghana, Kenya, Ethiopia, Uganda, and Nigeria. Dr. Miller is a co-investigator with Dr. Janet Turan’s research on the effects of the HIV epidemic on maternal health services delivery She is the mentor to Dr. Katherine Todd’s study of peri-natal infections among pregnant women and to Dr. Sadia Haider’s study of near-miss maternal mortality; both of which are in Afghanistan. Dr. Miller’s expertise is called upon on international technical consultations by bi-lateral organizations, such as WHO and UNICEF. She is on the Expert Panel on Induction and Augmentation of Labor, the California Maternal Quality Care Collaboratives Hemorrhage Task Force, and heads the Prevention of Post Partum Hemorrhage Initiative’s (POPPHI) First Interventions Task Force. Dr. Miller has traveled to South Africa, Yemen, Afghanistan, Jordan, India, China, Vietnam, and Thailand in addition to site visits to her ongoing projects. She has published over 50 journal articles, including a paper she co-authored that won the Society of Medical Anthropology’s Polgar Prize (Challenge of Cross-Cultural Clinical Trials Research: Case Report from the Tibetan Autonomous Region, People’s Republic of China. Medical Anthropology Quarterly, 19 (3): 267-89). She is co-author on the Hesperian Foundation's Book for Midwives, which was awarded the American College of Nurse Midwives’ Notable Book of the Year Award in 2006. Areas of Interest: Obstetric Hemorrhage
Evidence-Based Obstetrical Medicine
International Safe Motherhood | | | | | Professor Michael Mbizvo (WHO, Geneva)
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. | | | |
Senior Management Team (SMT) | Professor Z Mike Chirenje, MD FRCOG Executive Director Biosketch: Mike Chirenje, MD FRCOG, is a Gynecological Oncologist & Associate Professor in the Department of Obstetrics and Gynecology College of Health Science, University of Zimbabwe, Harare. His main research interest is cervical cancer screening and treatment of pre-cancer lesions in low resource settings. He is a member of WHO HPV Vaccine Expert Advisory Committee, and board member of African Organisation on Research and Training in Cancer. He is a founding member and Executive Director of a large Harare based collaborative Research Programme University of Zimbabwe – University of California San Francisco. Dr Chirenje was Principal Investigator for a large protocol that screened 11 000 women in Harare which became internationally a milestone study to demonstrate effectiveness of VIA in screening cervical cancer in low resource countries. Dr. Chirenje is currently Principle Investigator for a WHO operative research protocol assessing implementation of Cervical Cancer Screening by visual inspection with acetic acid and cyrotheray treatment in six African countries (Nigeria, Malawi, Zambia, Madagascar, Tanzania and Uganda) Dr. Chirenje has also evaluated HPV screening and he is currently following a cohort to establish HPV types among Zimbabwean women with invasive cervical cancer. He is also Principal Investigator for a large NIH funded HIV Clinical Trials unit (UZ-UCSF) that is evaluating several HIV prevention methods including vaginal microbicides in HIV uninfected women as well as oral pre-exposure prophylaxis (Pr-EP) of anti-retroviral drugs. | | | | | Mrs. Pangisile Matikiti Administrative Director
Mrs Pangisile Matikiti, BAcc Sc, joined UZ-UCSF Research Programme as the Programme Administrative Director on 1st of November 2007. Mrs Matikiti is a qualified business manager with over 25 years’ experience in managing a variety of businesses. At the time of joining UZ-UCSF, Matikiti was the Managing Director for a Leather and Shoe manufacturing concern in Zimbabwe – G and D Holdings, after 2 years with Merspin Limited as Finance Director, a year in Malawi with a Health NGO as Administrator, 10 years with Edgars Stores as Group Financial Accountant and a 10 year professional contact with Deloitte & Touché Zimbabwe. A distinguished senior manager, a management systems specialist and non executive board member in a number of Zimbabwean companies. | | | | | | Prisca Manyani - Head of Accounts Miss Prisca Manyani is a holder of Bachelor of Accountancy Honours (B Acc Hons) from University of Zimbabwe, Bachelor of Accounting Science (B Compt Hons) from UNISA and Zimbabwe Certificate of Theory in Accounting (ZCTA) from Institute of Chartered Accountants in Zimbabwe. Prisca joined UZ-UCSF Research Programme as an Accounting consultant from the 9th of February 2009 and assumed the position of Head Of Accounts with effect from the 1st of February 2010. Prior to joining the programme she served Articles of Clerkship with the now BDO Zimbabwe Chartered Accountants formely BDO Kudenga And Co CA (Z) where she got invaluable experience and exposure in various business sectors. Prisca is a hard working, dedicated and highly analytical team player, willing and committed to working in a business environment. | | | | | Dr. Charles Chiedza Maponga - Pharm.D, MHPE Pharmacy Director and Consultant Biosketch Dr. Maponga is Senior Lecturer in Clinical Pharmacy in the UZ College of Health Sciences and he is the Program Director for the International Center for HIV Pharmacology Research in Zimbabwe. He is also a special projects advisory member to the Medicines Control Authority Zimbabwe and a member of the Pharmacists Council of Zimbabwe. Dr Maponga acts as a unique member of the research team who provides advice on Pharmacy related issues as well as essential collaboration between Health Sciences training and research programs in Zimbabwe. He has extensive training and skills in the implementation of antiretroviral medication programs and the implementation of pharmacologic approaches to monitoring HIV drug therapy. Dr Maponga has been actively involved in the Adult Clinical Trials Group’s Pharmacology Committee and is a protocol pharmacologist for ACTG 5208. His involvement has been partly through his linkage with the School of Pharmacy of the State University of New York at Buffalo where he holds the position of visiting International HIV Pharmacology Research Scientist. He is co-investigator in a recently awarded NIH Fogarty International Center’s AIDS International Training and Research Program (AITRP) grant to develop HIV Clinical Pharmacology Research Programs in southern Africa. | | | | | Prof Zvenyika A Gomo, PHD Laboratory Director Biosketch
Zvenyika A. R. Gomo PhD is the Professor of Chemical pathology at the College of Health sciences, University of Zimbabwe. Prof ZAR Gomo received his PhD in Chemical pathology at Birmingham University UK in 1982. Training in all aspects of Clinical Biochemistry, he did postdoctoral fellowship at Center for Disease Control, Atlanta Georgia in 1986 on advanced high resolution methods for characterizing proteins in health and disease. The principal themes of his research have been on: 1) Development of high resolution protein separation techniques; 2) The study of genetic of iron overload; identification/monitoring biochemical markers of diseases of public health importance e.g. cardiovascular disease, tumour markers; 3) and recently the study of chemical pathology of infectious diseases focusing on the metabolic complications of ARVs. Administratively Prof Gomo has held the following posts; 1) Chairman of department; 2) Chairman of the division of pathology; 3) Dean of medical school. The Professor brings into the UZ-UCSF Programme, an in depth experience in research, diagnostic clinical laboratory testing and administration. |
The SMT is the operational arm of the Executive Committee responsible for the day to day execution of activities and the development of policies/Standard Operating Procedures (SOPs) for the Program. Overview of Organizational Structure 
Collaborating Institutions University of California at San Francisco (UCSF) - Prof Nancy Padian WHO, Geneva - Prof Mike Mbizvo Stanford University - Dr. Yvonne Maldonado
University of Colorado - Dr Tom Campbell University College London - Dr. Frances Cowan |
